Back to search

Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patients

Data up to Jan 2025

Published2002
Citations72
References33

Total Citations Per Year

Abstract

References (33)

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

1997 • 3,167 citations

Cancer statistics, 1998

1998 • 2,407 citations

SYFPEITHI: database for MHC ligands and peptide motifs

1999 • 2,307 citations

Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma

1988 • 2,196 citations

Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2

1994 • 991 citations

Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer

1998 • 672 citations

Immunotherapy of Hormone-Refractory Prostate Cancer With Antigen-Loaded Dendritic Cells

2000 • 627 citations

The Telomerase Catalytic Subunit Is a Widely Expressed Tumor-Associated Antigen Recognized by Cytotoxic T Lymphocytes

1999 • 574 citations

Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer

2000 • 422 citations

Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses

2000 • 407 citations

Cancer vaccines based on the identification of genes encoding cancer regression antigens

1997 • 395 citations

Telomerase activity: a prevalent marker of malignant human prostate tissue.

1996 • 394 citations

Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.

2001 • 313 citations

Cytotoxic T cell immunity against telomerase reverse transcriptase in humans

2000 • 259 citations

Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients.

2001 • 258 citations

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

1999 • 242 citations

Identification of Ny-Eso-1 Epitopes Presented by Human Histocompatibility Antigen (Hla)-Drb4*0101–0103 and Recognized by Cd4+T Lymphocytes of Patients with Ny-Eso-1–Expressing Melanoma

2000 • 232 citations

Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides.

2000 • 218 citations

Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts

2001 • 185 citations

Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.

1999 • 159 citations

Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide

1996 • 155 citations

A novel dendritic cell population in human blood: one-step immunomagnetic isolation by a specific mAb (M-DC8) andin vitro priming of cytotoxic T lymphocytes

1998 • 151 citations

Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.

2000 • 145 citations

Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.

2001 • 145 citations

The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor α spots in response to peptide antigens

1997 • 142 citations

Generation of PSA-reactive effector cells after vaccination with a PSA-based vaccine in patients with prostate cancer

2000 • 127 citations

Generation of Human Cytolytic T Lymphocyte Lines Directed Against Prostate-Specific Antigen (PSA) Employing a PSA Oligoepitope Peptide

1998 • 126 citations

Presentation of prostate tumor antigens by dendritic cells stimulates T-cell proliferation and cytotoxicity

1996 • 120 citations

Induction of prostate tumor-specific CD8+ cytotoxic T-lymphocytes in vitro using antigen-presenting cells pulsed with prostatic acid phosphatase peptide

1998 • 114 citations

An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells

1995 • 91 citations

High frequencies of circulating melanoma-reactive CD8+ T cells in patients with advanced melanoma

2000 • 51 citations

Insect cells as HLA-restricted antigen-presenting cells for the IFN-γ Elispot assay

2000 • 24 citations

clone recognizing a wild-type p53-derived peptide Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte

1996 • 11 citations

Cited By (0)

No citing papers found in database

Prostate stem cell antigen: Identification of immunogenic peptides and assessment of… (2002) – International Journal of Cancer | Metascience Observatory Explorer